LitAlert ~~ GeneLit.com

    • Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer.
    • Toh MR, Low CE, Chong ST, Chan SH, Binte Ishak ND, Courtney E, Kolinjivadi AM, Rodrigue A, Masson JY, Ngeow J.
    • Fam Cancer. 2020 Feb 11. doi: 10.1007/s10689-020-00163-8. [Epub ahead of print]
    • Myriad Files sPMA With FDA for Test to ID Best Responders to Lynparza, Avastin Combination.
    • [No author given]
    • GenomeWeb. 2020 Feb 11.
    • Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
    • da Costa E Silva Carvalho S, Cury NM, Brotto DB, de Araujo LF, Rosa RCA, Texeira LA, Plaça JR, Marques AA, Peronni KC, Ruy PC, Molfetta GA, Moriguti JC, Carraro DM, Palmero EI, Ashton-Prolla P, de Faria Ferraz VE, Silva WA Jr.
    • BMC Med Genomics. 2020 Feb 10;13(1):21. doi: 10.1186/s12920-019-0652-y.
    • Does Medicare-eligible high-risk breast cancer screening MRI target the right women?
    • Lo G, McLaughlin A, Jacques A, Dhillon R, Porter G, Jayaratne T, Bose S, Bourke A.
    • J Med Imaging Radiat Oncol. 2020 Feb 9. doi: 10.1111/1754-9485.13009. [Epub ahead of print]